Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,755.56
(
0.65%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122817
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Mufaso post# 218257

Tuesday, 04/03/2018 5:17:47 PM

Tuesday, April 03, 2018 5:17:47 PM

Post# of 257302

Isn't RT002 is being talked about in the medical community in "what if" terms?

Yes, of course. RT002 is being discussed implicitly by asking injectors (e.g.) what they think about a botulinum-toxin product with an extended duration compared to Botox.

What can RVNC legally do/say before approval to possible patients/doctors? For that matter do you know what AGN can legally say and do?

As a practical matter, the FDA and DoJ are unlikely to pursue either company for merely talking book this far in advance of RT002’s commercial launch.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up